DuPont de Nemours adjusted its outlook for the year following a solid second-quarter performance that it said more than ...

The “Back to School Bash" on Saturday will provide free physical exams, vaccinations, and lead testing to children in grades ...

Jacksonville, Fla.-based Nemours Children’s Health has named Eduardo Novais, MD, chair of its orthopedics department, according to an Aug. 8 system release.  Dr. Novais will lead orthopedic and sports ...

Analysts have set 12-month price targets for DuPont de Nemours, revealing an average target of $88.5, a high estimate of $93.00, and a low estimate of $85.00. Witnessing a positive shift, the current ...

US$227.0m (up 34% from 2Q 2024). Profit margin: 7.0% (up from 5.3% in 2Q 2024). EPS: US$0.54 (up from US$0.40 in 2Q 2024). We ...

DuPont de Nemours, Inc. posts strong Q2 results, boosts guidance, and prepares for the Qnity spin-off, unlocking growth ...

The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $1.06 per share. The specialty ...

For the quarter ended June 2025, DuPont de Nemours (DD) reported revenue of $3.26 billion, up 2.7% over the same period last year. EPS came in at $1.12, compared to $0.97 in the year-ago quarter. The ...

In $2B settlement, DuPont agrees to fund remediation at four toxic sites, including the giant Chambers Works facility, but ...

Shares of DuPont de Nemours Inc. DD advanced 1.39% to $70.91 Monday, on what proved to be an all-around positive trading ...

Let Nemours’ success be a reminder of how we can do better for all by daring for push for change. Florida politicians shouldn’t let tourism bosses call the shots.

The chemical-and-materials maker on Tuesday forecast sales around $12.85 billion and adjusted earnings per share around $4.40. The Wilmington, Del., company previously guided for sales between $12.8 ...